Frederick ThielenCurrent Challenges in Health Technology Assessment:Assessing costs and cost-effectiveness of novel treatments in haemato-oncology December 16, 2020
Chiara WichelloPatient Preferences throughout the Medical Product LifecycleDecember 9, 2020
Anne-Claire PeultierCost-effectiveness modelling of complex diagnostic strategies in cardiovascular diseases; early HTA supporting healthcare decision makingDecember 3, 2020
Saskia SchawoEconomic Evaluation of Treatment for Externalizing Disorders in Adolescents: Connecting mental health and economicsDecember 19, 2019
Andrija Grustam Cost-effectiveness, Care Coordination, and Business Model Innovation in Telehealth for Chronic Heart Failure Patients7 December 2018
Maartje GoordenCost-Utility of Collaboration Models in Mental Health Care20 September 2018
Amir AnsaripourImproving Decision-Making for Drug Reimbursement in Iran6 July 2018
Dan PoenaruGlobal Burden of Pediatric Surgical DiseaseOpens external20 April 2017
Tim KantersHealth Technology Assessment Of Orphan Drugs:The example of Pompe disease8 December 2016
Leander BuismanEarly Cost-Effectiveness of Medical Tests in Rheumatoid Arthritis and Ischemic Stroke30 June 2016
Hedwig Maria Sluimer-BlommesteinThe Added Value of Real-World Evidence1 April 2016
